133 related articles for article (PubMed ID: 25614447)
1. Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Qiu F; Yang L; Ling X; Yang R; Yang X; Zhang L; Fang W; Xie C; Huang D; Zhou Y; Lu J
Clin Cancer Res; 2015 Apr; 21(7):1602-13. PubMed ID: 25614447
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma.
Qiu F; Yang L; Zhang L; Yang X; Yang R; Fang W; Wu D; Chen J; Xie C; Huang D; Zhou Y; Lu J
Gene; 2015 Jul; 565(2):180-6. PubMed ID: 25861865
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
[TBL] [Abstract][Full Text] [Related]
4. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
[TBL] [Abstract][Full Text] [Related]
5. Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population.
Zhan X; Wu W; Han B; Gao G; Qiao R; Lv J; Zhang S; Zhang W; Fan W; Chen H; Zhang T; Gu A; Shen J; Wu Q; Lu D
J Clin Lab Anal; 2012 Nov; 26(6):441-6. PubMed ID: 23143626
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in microRNAs predict non-small cell lung cancer prognosis in Chinese female population in a prospective cohort study.
Lingzi X; Zhihua Y; Xuelian L; Yangwu R; Haibo Z; Yuxia Z; Baosen Z
Oncotarget; 2016 Dec; 7(50):83101-83114. PubMed ID: 27825117
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
[TBL] [Abstract][Full Text] [Related]
8. Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
Fang C; Li XP; Gong WJ; Wu NY; Tang J; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():21-29. PubMed ID: 27873337
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy.
Xu S; Li J; Chen L; Guo L; Ye M; Wu Y; Ji Q
Medicine (Baltimore); 2019 Oct; 98(42):e17335. PubMed ID: 31626089
[TBL] [Abstract][Full Text] [Related]
10. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
[TBL] [Abstract][Full Text] [Related]
11. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.
Cheng M; Yang L; Yang R; Yang X; Deng J; Yu B; Huang D; Zhang S; Wang H; Qiu F; Zhou Y; Lu J
Carcinogenesis; 2013 Oct; 34(10):2292-9. PubMed ID: 23715500
[TBL] [Abstract][Full Text] [Related]
12. Association between common genetic variants in pre-microRNAs and prognosis of advanced gastric cancer treated with chemotherapy.
Tahara T; Okubo M; Shibata T; Kawamura T; Sumi K; Ishizuka T; Nagasaka M; Nakagawa Y; Arisawa T; Ohmiya N; Hirata I
Anticancer Res; 2014 Sep; 34(9):5199-204. PubMed ID: 25202115
[TBL] [Abstract][Full Text] [Related]
13. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival.
Xie K; Ma H; Liang C; Wang C; Qin N; Shen W; Gu Y; Yan C; Zhang K; Dai N; Zhu M; Wu S; Wang H; Dai J; Jin G; Shen H; Hu Z
Oncotarget; 2015 Dec; 6(40):42781-92. PubMed ID: 26543233
[TBL] [Abstract][Full Text] [Related]
14. [Target-resequencing to identify microRNA-associated SNP and predict the effect of SNP on microRNA function in colorectal cancer patients].
Qiu Q; Liu J; Shao J; Lou X; Chen C; Lin B
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):759-63. PubMed ID: 26813595
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of miRNA sequences and non-small cell lung cancer survival.
Hu Z; Chen J; Tian T; Zhou X; Gu H; Xu L; Zeng Y; Miao R; Jin G; Ma H; Chen Y; Shen H
J Clin Invest; 2008 Jul; 118(7):2600-8. PubMed ID: 18521189
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Single Nucleotide Polymorphisms of an miRNA Binding Site in the 3'UTR of
Yu A; Zhang J; Mei Y; Zhong H; Chen S; Song Q
Genet Test Mol Biomarkers; 2020 Jul; 24(7):381-389. PubMed ID: 32552146
[No Abstract] [Full Text] [Related]
17. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.
Gao W; Shen H; Liu L; Xu J; Xu J; Shu Y
J Cancer Res Clin Oncol; 2011 Apr; 137(4):557-66. PubMed ID: 20508945
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population.
Wu S; Shen W; Yang L; Zhu M; Zhang M; Zong F; Geng L; Wang Y; Huang T; Pan Y; Cao S; Dai J; Ma H; Wu J
Cancer Med; 2019 May; 8(5):2636-2645. PubMed ID: 30843663
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
Li J; Feng Q; Wei X; Yu Y
Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
